AstraZeneca PLC

 

1 Francis Crick Avenue

 

Cambridge Biomedical Campus

 

Cambridge, CB2 0AA

 

United Kingdom

 

T: +44 (0) 20 3749 5000

 

 

 

astrazeneca.com

 

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

February 16, 2021

 

Re:             Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

 

Ladies and Gentlemen,

 

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that AstraZeneca PLC has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February, 16 2021. The disclosure can be found under the heading “Item 4.B Business Overview—Disclosures Under the Iran Threat Reduction and Syria Human Rights Act of 2012” in the Annual Report on Form 20-F.

 

 

AstraZeneca PLC

 

Registered in England No. 2723534

 

Registered office: 1 Francis Crick Avenue

 

Cambridge Biomedical Campus

 

Cambridge, CB2 0AA

 

United Kingdom

 


 

Respectfully submitted,

 

 

/s/  A C N Kemp

 

 

 

 

 

A C N Kemp

 

Authorized Signatory

 

AstraZeneca PLC

 

 

 

AstraZeneca PLC

 

Registered in England No. 2723534

 

Registered office: 1 Francis Crick Avenue

 

Cambridge Biomedical Campus

 

Cambridge, CB2 0AA

 

United Kingdom

 

2


AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more AstraZeneca Charts.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more AstraZeneca Charts.